Non-cardiology care for HFrEF was associated with lower use of guideline-based therapies and a higher risk of 1-year all-cause mortality (HR 1.09; 95% CI 1.03-1.15) compared to cardiology care.
Cohort (n=36,076)
Yes
Does management in non-cardiology settings compared to cardiology settings affect mortality and heart failure hospitalization in patients with HFrEF?
Management of HFrEF patients in non-cardiology settings is associated with lower use of guideline-directed medical therapy and devices, and higher 1-year all-cause mortality compared to cardiology care.
Hazard Ratio: 1.09 (95% CI 1.03–1.15)
BACKGROUND: Patients with heart failure (HF) are often cared for by non-cardiologists. The implications are unknown. METHODS: In a nationwide HF cohort with reduced ejection fraction (HFrEF), we compared demographics, clinical characteristics, guideline-based therapy use and outcomes in non-cardiology vs. cardiology in-patient and out-patient care. RESULTS: Between 2000 and 2016, 36,076 patients with HFrEF were enrolled in the Swedish HF registry (19,337 54% in-patients overall), with 44% of in-patients and 45% of out-patients managed in non-cardiology settings. Predictors of treatment in non-cardiology were age > 75 years (adjusted odds ratio for non-cardiology 1.20; 95% confidence interval 1.14-1.27), lower education level (0.71; 0.66-0.76 for university vs. compulsory), valve disease (1.24; 1.18-1.31) and systolic blood pressure (SBP) >120 mmHg (1.05; 1.00-1.10). Non-cardiology care was significantly associated with lower use of beta-blockers (0.80; 0.74-0.86) and devices (intracardiac defibrillator ICD and/or cardiac resynchronization therapy CRT: 0.63; 0.56-0.71), and less frequent specialist follow-up (0.61; 0.57-0.65). Over 1-year follow-up the risk of all-cause mortality (adjusted hazard ratio 1.09; 1.03-1.15) was higher but the risk of first HF (re-) hospitalization was lower (0.93; 0.89-0.97) in non-cardiology vs. cardiology care. CONCLUSIONS: In HFrEF, non-cardiology care was independently associated with older ageand lower education. After covariate adjustment, non-cardiology care was associated with lower use of beta-blockers and devices, higher mortality, and lower risk of HF hospitalization. Access to cardiology care may not be equitable and this may have implications for use of guideline-based care and outcomes.
Kapelios et al. (Fri,) conducted a cohort in Heart failure with reduced ejection fraction (HFrEF) (n=36,076). Non-cardiology care vs. Cardiology care was evaluated on All-cause mortality (HR 1.09, 95% CI 1.03-1.15). Non-cardiology care for HFrEF was associated with lower use of guideline-based therapies and a higher risk of 1-year all-cause mortality (HR 1.09; 95% CI 1.03-1.15) compared to cardiology care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: